novo nordisk glp 1 drug Nordisk's Wegovy pill launch draws new wave of patients to GLP-1s GLP-1 Drug Fails to Quell

I., Spyrou, N., Mantzoros, C

Individuals with type 2 diabetes typically experience an impaired incretin effect, though GLP-1 secretion itself may be normal, slightly reduced, or context-dependent

(Well come back to this in the genetics section) The following diagram illustrates how proglucagon is cleaved into its various components: Why GLP-1 Is Broken Down So Fast (DPP-4) The GLP-1 hormone has a remarkably short half-life of around 2 minutes

As journals and articles are increasingly placed behind paywalls, access to scientific information for the sake of reviews such as this become only further limited and only add to the challenges of providing a comprehensive review of the literature

As a nutritionist, I understand that all tools in our toolkit that could help people achieve their desired goal should be welcome and assessed for its benefits and risks